Publication | Open Access
Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells
76
Citations
40
References
2022
Year
B regulates KEAP1/NRF2 signaling, drives metabolic rewiring, CpG methylomic, and transcriptomic reprogramming contributing to the overall cancer-prevention/anticancer effect in the CRC cell model.
| Year | Citations | |
|---|---|---|
Page 1
Page 1